Author

Kazuhiro Nishiyama

Observed name: Kazuhiro NISHIYAMA

Institution: St. Marianna University School of Medicine

Observed institutions: Kyushu University, St. Marianna University School of Medicine, Kansai Electric Power (Japan), Kansai Electric Power Hospital, Osaka Metropolitan University

ORCID: 0009-0006-9673-9820

Observed ORCID: 0009-0006-9673-9820

OpenAlex ID: A5046327404

L-arginine-induced pancreatitis aggravated by inhibiting Na+/Ca2+ exchanger 1

2023 · Naoshige ONO, Joji HORIKOSHI, et al. · Journal of Veterinary Medical Science · 11

Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis

2025 · Toshiya Fujisaki, Eisaku Miyauchi, et al. · Lung Cancer · 4

Clinical outcomes of tepotinib and immune checkpoint inhibitor therapy for MET exon 14 skipping NSCLC: A multicentric retrospective analysis.

2025 · Kazuhito Misawa, Kageaki Watanabe, et al. · Journal of Clinical Oncology · 1

Functional role of IL-19 in a mouse model of L-arginine-induced pancreatitis and related lung injury

2023 · Naoshige Ono, Joji Horikoshi, et al. · EXPERIMENTAL ANIMALS · 1

Clinicopathological Features of DLL3 Expression and T‐Cell Infiltration in LCNEC : Insights From Pathology and Clinical Response to Tarlatamab

2026 · Shotaro Kaneko, Naoki Furuya, et al. · Thoracic Cancer

Pharmacological inhibition of Na+/Ca2+ exchanger alleviates colitis via modulation of macrophage activity in multiple species

2025 · Kazuhiro Nishiyama, Eiichi Hinoi, et al. · International Immunopharmacology

Surgical management of pancreatic neuroendocrine neoplasms

2023 · Izumi KOMOTO, Atsushi YOSHIZAWA, et al. · Suizo

Acknowledgement to Referees for Pharmacology 2014

2014 · Marc Verleye, Philippe Girard, et al. · Pharmacology

Works count: 8

Citation count: 17

H-index: 2

I10-index: 1